Patent · US Active

Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors

US9856234B2 · kind B2 · utility

0Cited by

10References

13Claims

0Family size

Assignees

Abb Vie Deutschland Gmbh & Co. KG · DE
Abb Vie Inc. · US

Inventors

Sean Colm Turner · Ludwigshafen, DE
Margaretha Henrica Maria Bakker · Ludwigshafen, DE
Kent D. Stewart · Gurnee, US

Key dates

Filing date	Jan 31, 2014
Grant date	Jan 2, 2018
Priority date	—
Expiry date	Jan 31, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a heterocyclic compound of the general formula (I) and their use and preparation, methods of making the compounds, compositions containing at least one of said compounds, and methods of treatment using at least one compound. In particular, compounds of the general formula (I) are useful for inhibiting glycogen synthase kinase 3 (GSK-3).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.